Hefei KS-V Peptide Biological Technology Co., Ltd.
Hefei KS-V Peptide Biological Technology Co., Ltd. https://www.difficultpeptide.com/
| 2022年 平成34年 |
- | 
WHAT DOES UBIQUITIN DO?(2022年)Ubiquitin is a highly conserved protein widely found in nuclear cells. It cooperates with ubiquitin… 
ABOUT KS-V PEPTIDE(2022年)Hefei KS-V Peptide is a pre-clinical new drug research and development CRO company based on structu… 
KSVP CULTURE(2022年)KSVP CULTURECompany MissionKSV Peptide focuses on high-quality peptide products and services and is… 
CUSTOM PEPTIDE SYNTHESIS(2022年)KS-V Peptide has always been committed to the research and development of advanced peptide synthesi… 
PEPTIDE DRUG DISCOVERY(2022年)With a team of experienced experts, advanced research equipment, and proprietary methods, KS-V Pept… 
GENE TO STRUCTURE(2022年)As a professional peptide company in China, we can provide innovative drugs from gene to protein, f… 
INTRODUCTION TO SBDD(2022年)Ⅰ.What is SBDD?Structure based drug design (SBDD) is a drug design method based on molecular recogn… |
| 2023年 平成35年 |
01月 | 
Common Histone H4(2023年01月05日)SPECIFICATION OF HISTONE H4CATH4100Product NameHistone H4Purity≥95% by HPLC analysisAppearanceW… 
H4K12ac(2023年01月07日)SPECIFICATION OF H4K12ACCATH4202Product NameHistone H4-K12acPurity≥95% by HPLC analysisAppearanc… 
H4K16ac(2023年01月09日)SPECIFICATION OF H4K16ACCATH4203Product NameHistone H4-K16acPurity≥95% by HPLC analysisAppearanc… 
H4K20ac(2023年01月11日)H4K20ACSynthesized histone H4 peptide corresponding to residues within 1-102 of human histone H4 wi… 
H4K8ac(2023年01月13日)H4K8ACSynthesized histone H4 peptide corresponding to residues within 1-102 of human histone H4 wit… 
Huwentoxin Iv(2023年01月15日)HUWENTOXIN IVTTX-sensitive Na+ channels, Huwentoxin-IV specifically inhibits the neuronal tetrodoto… 
Iberiotoxin(2023年01月17日)IBERIOTOXINKCa1.1 K+ channels, Iberiotoxin is a potent selective blocker of the high conductance Ca… 
Kaliotoxin(2023年01月19日)SPECIFICATION OF KALIOTOXINCATK1070-VCAS NO.145199-73-1Product NameKaliotoxinPurity> 98%Form… |
| 03月 | 
SYN AKE(2023年03月)Tripeptide-3, also known as dipeptide diaminobutyryl benzyl amide diacetate or SYN®-AKE, mimics the… 
PLECANATIDE(2023年03月03日)Polypeptides is a minimally absorbed agonist of guanylate cyclase C receptors in the intestine and … 
PLTX II(2023年03月03日)SNX482Selective, irreversible presynaptic voltage-gated Ca2+ channel blocker. Potent neurotoxin. Se… 
PROTOXIN II(2023年03月03日)NaV channels and T-type Ca2+ channels, Protx-II inhibits NaV channels1. Protx-II could also modulat… 
PSALMOTOXIN 1(2023年03月03日)ASIC1a channels, Psalmotoxin-1 inhibits cation currents mediated by acid-sensing ion channels (ASIC… 
SEMAGLUTIDE AND IMPURITY(2023年03月03日)Semaglutide Peptide for Sale"Natural semaglutide is a recombinant DNA produced polypeptide ana… 
SHK TOXIN(2023年03月03日)Various KV K+ channels. Stichodactyla Toxin blocks KV1.3, KV1.1, KV1.4, and KV1.6 at subnanomolar c… 
SYN AKE(2023年03月03日)Tripeptide-3, also known as dipeptide diaminobutyryl benzyl amide diacetate or SYN®-AKE, mimics the… 
UB AMC(2023年03月03日)Ubiquitin AMC is prepared by the C-terminal derivatization of ubiquitin with 7-amino-4-methylcoumar… |
|
| 05月 | 
WHAT DOES UBIQUITIN DO?(2023年05月01日)Ubiquitin is a highly conserved protein widely found in nuclear cells. It cooperates with ubiquitin… 
PEPTIDE SERVICES CENTER(2023年05月02日)ABOUT KS-V PEPTIDEMORE ABOUT KS-V PEPTIDEABOUT KS-V PEPTIDEHefei KS-V Peptide is a pre-clinical new… 
KS-V PEPTIDE CULTURE(2023年05月03日)KS-V Peptide CultureCompany MissionKSVP focuses on high-quality peptide products and services and i… 
Custom Peptide Synthesis(2023年05月04日)KS-V Peptide has always been committed to the research and development of advanced peptide synthesi… 
Drug Discovery(2023年05月05日)With a team of experienced experts, advanced research equipment, and proprietary methods, KS-V Pept… 
Gene to Structure(2023年05月06日)As a professional peptide company in China, we can provide innovative drugs from gene to protein, f… 
INTRODUCTION TO SBDD(2023年05月07日)Ⅰ.What is SBDD?Structure based drug design (SBDD) is a drug design method based on molecular recogn… |
- この年表のURL:
